New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 11, 2014
14:56 EDTCEMPCempra to present data on solithromycin at ECCMID
Cempra announced that it will present data at the European Congress of Clinical Microbiology and Infectious Diseases, ECCMID, in Barcelona, Spain, that continue to enhance the profile of solithromycin in regards to potential new indications, safety and spectrum of activity particularly against contemporary strains. Presentations will occur on Saturday, May 10 to Tuesday, May 13.Prabhavathi Fernandes, Ph.D., president and chief executive officer of Cempra said, "We continue to collect exciting data on the emerging profile of solithromycin, our fourth-generation macrolide. The data presented at this year's ECCMID are excellent examples of that trend. Proof of concept in otitis media was presented and this adds to the broadening use potential of solithromycin that includes pediatric use, infections in pregnancy, gonorrhea and non-infectious diseases such as COPD and NASH among others. We also presented the full hepatic insufficiency study that we announced in 3Q13, which demonstrated the benign tolerability profile seen to date. The emerging safety profile is promising based on this study as well as the safety profile seen in our Phase 2 CABP trial and the lack of a QT effect in our Thorough QT study."
News For CEMP From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 17, 2015
08:04 EDTCEMPStifel to hold a conference
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use